Joel Greenblatt · Magic Formula: high return on capital at a cheap EV/EBIT
Is ANI Pharmaceuticals, Inc. (ANIP) a Joel Greenblatt Stock?
Low Magic Formula score: expensive, low ROIC, or both.
38/100
Does not fit
1/5 criteria passed
Joel Greenblatt's Criteria, Applied to ANIP
EBIT/EV yield ≥ 10%
key4.5%
ROIC ≥ 25%
key8.2%
EV/EBIT ≤ 12
22.2x
Gross margin ≥ 30%
65.9%
How ANIP Scores on Other Strategies
Live Financial Snapshot
Market cap
$1.65B
P/E (TTM)
21.1x
ROIC (TTM)
8.17%
Gross margin
61.36%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is ANIP's Joel Greenblatt fit score?
ANIP scores 38/100 on our Joel Greenblatt fit engine. Low Magic Formula score: expensive, low ROIC, or both.
Does Joel Greenblatt actually own ANIP?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends ANIP.
How often is this score updated?
ANIP's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends ANIP.
